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Summary	Noroviruses	 produce	 viral	 RNAs	 lacking	 a	 5’	 cap	 structure	 and	 instead	 use	 a	virus-encoded	 VPg	 protein	 covalently	 linked	 to	 viral	 RNA	 to	 interact	 with	translation	 initiation	 factors	 and	 drive	 viral	 protein	 synthesis.	 Norovirus	infection	 results	 in	 the	 induction	 of	 the	 innate	 response	 leading	 to	 interferon	stimulated	gene	(ISG)	transcription.	However	the	translation	of	the	induced	ISG	mRNAs	 is	 suppressed.	 A	 SILAC-based	 mass	 spectrometry	 approach	 was	employed	 to	 analyse	 changes	 to	 protein	 abundance	 in	 both	 whole	 cell	 and	m7GTP-enriched	 samples	 to	 demonstrate	 that	 diminished	 host	 mRNA	translation	 correlates	 with	 changes	 to	 the	 composition	 of	 the	 eukaryotic	initiation	factor	complex.	The	suppression	of	host	ISG	translation	correlates	with	the	 activity	 of	 the	 viral	 protease	 (NS6)	 and	 the	 activation	 of	 cellular	 caspases	leading	to	the	establishment	of	an	apoptotic	environment.	These	results	indicate	that	 noroviruses	 exploit	 the	 differences	 between	 viral	 VPg-dependent	 and	cellular	 cap-dependent	 translation	 in	 order	 to	 diminish	 the	 host	 response	 to	infection.			
Introduction:	Noroviruses	 are	 the	 causative	 agent	 of	 the	 majority	 of	 human	 viral	gastroenteritis	 cases	 in	 the	developed	world	 (1).	Globally,	 they	are	 responsible	for	an	estimated	200,000	deaths	in	children	under	the	age	of	five	in	developing	countries,	 and	 in	 developed	 countries	 noroviruses	 are	 a	 major	 burden	 on	national	healthcare	 infrastructure	due	 to	closed	wards	and	economic	costs	 (1).	Noroviruses	are	 small,	 single-stranded,	positive-sense	RNA	viruses	best	known	for	 infecting	 humans,	 but	 several	 animal-specific	 noroviruses	 have	 also	 been	identified	(2,	3).			As	members	of	the	Caliciviridae,	noroviruses	use	a	virus-encoded	VPg	protein	in	place	 of	 a	 5’	 cap	 structure	 to	 recruit	 eukaryotic	 initiation	 factors	 and	 direct	translation	 of	 viral	 RNAs	 (4–7).	 The	 norovirus	 non-structural	 proteins	 are	generated	by	the	cleavage	of	a	large	polyprotein	by	the	viral	protease	NS6	(Fig.	1A)	 (8,	 9)	 whereas	 the	 structural	 proteins	 VP1	 and	 VP2	 are	 produced	 from	 a	subgenomic	 mRNA	 produced	 during	 replication	 (10).	 In	 the	 case	 of	 murine	norovirus	(MNV),	the	only	norovirus	that	can	undergo	efficient	replication	in	cell	culture,	 a	 single	 overlapping	 reading	 frame	 encoding	 a	 virulence	 factor	 is	 also	present	 within	 the	 VP1	 coding	 region	 (11).	 Members	 of	 the	 Norovirus	 genus	appear	 distinct	 from	 other	 caliciviruses	 in	 that	 VPg	 interacts	 directly	with	 the	scaffolding	 protein	 eIF4G	 (4,	 6),	with	 this	 representing	 the	 key	 interaction	 for	viral	translation,	rather	than	the	cap-binding	protein	eIF4E	(7,	12,	13),	a	further	departure	 from	 the	 usual	 cap-dependent	mechanism	 of	 protein	 translation.	 In	addition	 we	 have	 also	 shown	 that	 norovirus	 infection	 causes	 eIF4E	phosphorylation,	 which	 may	 lead	 to	 the	 preferential	 translation	 of	 distinct	subsets	 of	 cellular	 mRNAs	 (14).	 Other	 viruses	 utilize	 discrepancies	 between	cellular	and	viral	 translation	 to	either	enable	more	efficient	 translation	of	viral	mRNA	in	the	presence	of	vastly	more	abundant	cellular	mRNA	(15),	or	to	inhibit	the	translation	of	cellular	mRNA	inhibitory	to	viral	infection	(16).			
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Studies	 using	 MNV,	 the	 most	 common	 model	 for	 the	 study	 of	 norovirus-host	interactions,	 have	 also	 confirmed	 the	 essential	 role	 that	 the	 innate	 response	plays	 in	 the	 regulation	 of	 norovirus	 infection	 and	 pathogenesis.	 MNV	 was	discovered	in	RAG/STAT1-/-	mice	(17),	and	more	recent	studies	have	shown	that	norovirus	 infection	 can	 be	 controlled	 and	 cleared	 through	 interferon	 λ,	 with	interferon	 α	 and	 β	 protecting	 the	 host	 from	 systemic	 infection	 even	 in	 the	absence	of	adaptive	immunity	(18,	19).	 	Noroviruses	are	thought	to	use	several	mechanisms	 to	 combat	 the	 immune	 response	 to	 infection	 (20).	 These	 include	disrupting	 protein	 export	 by	 the	 human	 norovirus	 NS1/2	 (21,	 22)	 or	 NS4	proteins	 (23,	 24)	 as	 well	 as	 diminishing	 interferon-stimulated	 gene	 (ISG)	induction	 through	 the	 activity	 of	 the	 MNV	 virulence	 factor	 VF1	 protein	 (11).	Despite	 these	 mechanisms,	 the	 interferon	 response	 is	 activated	 during	 both	natural	 infection	 in	humans	 (25)	or	 in	mice	 infected	with	MNV	 (18)	 leading	 to	the	induction	of	ISG	transcription.	A	recent	study	suggests	that	human	norovirus,	whilst	 sensitive	 to	 interferon,	 is	 a	 poor	 inducer	 of	 the	 interferon	 response	 in	vitro,	 albeit	 in	 conditions	where	viral	RNA	 is	 transfected	 into	cells	 leading	 to	a	limited	 number	 of	 cells	 undergoing	 active	 viral	 replication	 (26).	 The	 recent	generation	of	an	enteroid	system	for	the	growth	and	culture	of	human	norovirus	will	enable	this	to	be	investigated	in	more	detail	(27).	Notwithstanding	this,	we	and	 others	 have	 observed	 that	 ISG	 gene	 induction	 observed	 following	murine	norovirus	 infection	 often	 does	 not	 correlate	 with	 the	 resulting	 levels	 of	 the	induced	protein	(11,	28),	suggesting	a	posttranscriptional	regulatory	mechanism	is	also	involved	in	the	control	of	the	innate	response.		Post-transcriptional	 control	 of	 host	 translation	 during	 apoptosis	 or	 viral	infection	 has	 been	 investigated	 previously	 with	 the	 primary	 mechanisms	involved	utilizing	either	phosphorylation	of	eIF2α,	or	the	cleavage	of	translation	initiation	 factors	by	viral	or	host	enzymes	 (16).	Of	note,	 the	 related	calicivirus,	feline	 calicivirus	 reduces	 cellular	 translation	 through	 the	 activity	 of	 a	 viral	protease	 in	 cleaving	 the	 cellular	 protein	 PABP	 (29),	 and	 the	 roles	 of	 the	picornavirus	 3C	 and	 2A	 proteases,	 or	 cellular	 caspases,	 in	 cleaving	 translation	initiation	 factors	 have	 been	 characterized	 extensively	 (16,	 30).	 However,	 the	similarities	or	otherwise	underlying	this	process	 in	MNV	had	yet	 to	be	studied,	and	 no	 previous	 attempt	 at	 applying	 quantitative	 proteomics	 to	 the	 study	 of	viral-mediated	modification	of	host	protein	synthesis	made.		We	 investigated	 the	 posttranscriptional	 regulation	 of	 ISG	 mRNA	 translation	during	 norovirus	 infection.	 SILAC-based	 quantitative	 proteomics	 was	 used	 to	identify	 specific	 changes	 to	 levels	 or	 activity	 of	 translation	 initiation	 factors	within	norovirus-infected	cells.	We	observed	that	alterations	to	the	translatome	due	to	norovirus	infection	were	caused	by	both	direct	viral	and	cellular	response	mechanisms,	resulting	in	the	specific	reduction	in	translation	of	cellular	mRNAs.	Inhibition	of	these	modifications	lead	to	the	restoration	of	ISG	translation	and	an	impact	on	viral	replication,	indicating	that	norovirus	infection	limits	the	ability	of	the	 innate	 immune	 response	 to	 combat	 infection	 by	 posttranscriptional	regulation	of	induced	mRNAs.			
Experimental	Procedures:	Cells	and	Viruses	
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Murine	RAW	264.7	and	BV-2	cells	were	used	for	 infection	experiments;	human	HEK-293T	 cells	 were	 used	 for	 the	 indicated	 transfection	 experiments.	 All	infections	 were	 performed	 with	 murine	 norovirus	 strain	 CW1	 (31).	 All	 titre	calculations	were	 performed	 by	 TCID50.	 All	 infections	were	 performed	 at	 high	MOI	(10	TCID50/cell)	unless	explicitly	indicated,	in	which	case	a	low	MOI	of	0.01	TCID50/cell	 was	 used.	 See	 Supplemental	 Experimental	 Procedures	 for	 more	details.		Cell	lysis	and	35S	Methionine	labeling	Cells	were	lysed	in	RIPA	buffer	for	analysis	of	whole	cell	extracts.	For	metabolic	labeling	 experiments	 utilizing	 35S-Methionine	media	was	 replaced	with	 DMEM	containing	 35S-methionine	 30	 minutes	 prior	 to	 the	 indicated	 time	 and	 the	samples	harvested	30	minutes	after	the	indicated	time	in	RIPA	buffer.		m7GTP-sepharose	enrichment	and	polysome	profiling	For	 analysis	 of	 the	 eukaryotic	 initiation	 factor	 (eIF)	 complex,	 initiation	 factors	were	enriched	on	m7GTP-sepharose	beads	(Jena	Biosciences)	 following	 lysis	 in	m7GTP	 lysis	 buffer	 as	 described	 in	 Chung	 et	 al.,	 2014.	 Polysome	profiling	was	accomplished	by	centrifuging	cytoplasmic	lysates	for	90	min	at	200,000	x	g	over	a	10-50%	sucrose	gradient	 and	analysed	using	an	 Isco	Fractionator	measuring	absorbance	 at	 254nm.	 	 For	 full	 details	 see	 Supplemental	 Experimental	Procedures.		Mass	spectrometry	analysis	Cells	were	grown	 in	DMEM	containing	stable	 isotope	 labeled	 forms	of	arginine	and	 lysine	 for	 5	 passages,	 with	 labeling	 confirmed	 by	 mass	 spectrometry.		Unlabeled	arginine	and	lysine	were	used	in	the	 ‘Light’	media,	R6	(13C6)	and	 	K4	(D4)	in	the	‘Medium’	media,	and	R10	(13C6,15N4)	and	K8	(13C6,15N2),	in	the	‘Heavy	media.	10cm2	dishes	containing	1x107	cells	were	used	as	input	for	both	m7GTP	experiments,	and	the	whole	cell	lysate	experiments,	yielding	a	minimum	of	1mg	total	protein	per	dish.	Samples	were	harvested	at	 the	 indicated	 timepoints	and	combined	following	either	lysis	or	m7GTP-sepharose	enrichment.	These	samples	were	 subject	 to	 SDS-PAGE	 electrophoresis,	 and	 processed	 by	 in-gel	trypsinisation	followed	by	LC-MS/MS	analysis	on	a	Orbitrap	Velos	instrument	at	the	University	of	Bristol.	For	the	whole	cell	lysate	experiments,	the	gel	lane	was	cut	 into	 10	 slices	 and	 each	 slice	 subjected	 to	 in-gel	 tryptic	 digestion	 using	 a	ProGest	 automated	 digestion	 unit	 (Digilab	 UK).	 For	 the	 m7GTP	 pulldown	experiments,	 the	samples	were	run	 into	a	precast	gel,	and	extracted	as	a	single	band	 for	 tryptic	 digestion.	 	 The	 resulting	 peptides	 were	 fractionated	 using	 an	Ultimate	 3000	 nanoHPLC	 system	 in	 line	 with	 an	 LTQ-Orbitrap	 Velos	 mass	spectrometer	(Thermo	Scientific).		In	brief,	peptides	in	1%	(vol/vol)	formic	acid	were	 injected	 onto	 an	 Acclaim	 PepMap	 C18	 nano-trap	 column	 (Thermo	Scientific).	After	washing	with	0.5%	(vol/vol)	acetonitrile	0.1%	(vol/vol)	formic	acid	peptides	were	resolved	on	a	250	mm	×	75	μm	Acclaim	PepMap	C18	reverse	phase	 analytical	 column	 (Thermo	 Scientific)	 over	 a	 150	min	 organic	 gradient,	using	7	 	 gradient	 segments	 (1-6%	solvent	B	over	1min.,	 6-15%	B	over	58min.,	15-32%B	over	58min.,	32-40%B	over	3min.,	40-90%B	over	1min.,	held	at	90%B	for	6min	and	then	reduced	to	1%B	over	1min.)	with	a	flow	rate	of	300	nl	min−1.		Solvent	A	was	0.1%	formic	acid	and	Solvent	B	was	aqueous	80%	acetonitrile	in	
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0.1%	formic	acid.	 	Peptides	were	ionized	by	nano-electrospray	ionization	at	2.1	kV	using	a	 stainless	 steel	 emitter	with	an	 internal	diameter	of	30	μm	(Thermo	Scientific)	 and	 a	 capillary	 temperature	 of	 250°C.	 Tandem	 mass	 spectra	 were	acquired	using	an	LTQ-	Orbitrap	Velos	mass	spectrometer	controlled	by	Xcalibur	2.1	 software	 (Thermo	 Scientific)	 and	 operated	 in	 data-dependent	 acquisition	mode.		The	Orbitrap	was	set	to	analyze	the	survey	scans	at	60,000	resolution	(at	m/z	400)	 in	 the	mass	range	m/z	300	to	2000	and	the	top	six	multiply	charged	ions	 in	 each	duty	 cycle	 selected	 for	MS/MS	 in	 the	LTQ	 linear	 ion	 trap.	 	 Charge	state	 filtering,	 where	 unassigned	 precursor	 ions	 were	 not	 selected	 for	fragmentation,	 and	 dynamic	 exclusion	 (repeat	 count,	 1;	 repeat	 duration,	 30s;	exclusion	list	size,	500)	were	used.		Fragmentation	conditions	in	the	LTQ	were	as	follows:	 normalized	 collision	 energy,	 40%;	 activation	 q,	 0.25;	 activation	 time	10ms;	and	minimum	ion	selection	intensity,	500	counts.		The	raw	data	files	were	processed	and	quantified	using	Maxquant	v1.5.5.1	 	and	searched	 against	 the	Uniprot	Mouse	 database	 (51,418	 entries,	 dated	May	 14th,	2016)	 plus	 a	 custom	 fasta	 file	 generated	 in-house	 containing	 the	 MNV-1	(accession	DQ285629)	protein	 sequences	 using	 the	 built-in	Andromeda	 search	engine	 (32).	 	Peptide	precursor	mass	 tolerance	was	set	at	4.5ppm,	and	MS/MS	tolerance	 was	 set	 at	 0.5Da.	 Search	 criteria	 included	 carbaminomethylation	 of	cysteine	 as	 a	 fixed	 modification.	 Oxidation	 of	 methionine	 and	 N-terminal	acetylation	were	selected	as	variable	modifications.	Quantification	was	based	on	Light	 (Arg	 0,	 Lys	 0)	 Medium	 (Arg	 6,	 Lys	 4)	 and	 Heavy	 (Arg	 10,	 Lys	 8)	 SILAC	labels.	Searches	were	performed	with	full	tryptic	digestion,	a	minimum	peptide	length	of	7	amino	acids,	and	a	maximum	of	2	missed	cleavages	were	allowed.	The	reverse	database	 search	option	was	 enabled	and	 the	maximum	 false	discovery	rate	 for	 both	 peptide	 and	 protein	 identifications	was	 set	 to	 0.01.	 Quantitation	was	 performed	 using	 a	 mass	 precision	 of	 2ppm	 and	 the	 requantify	 option	 in	Maxquant	was	enabled.	The	presented	protein	ratios	represent	the	median	of	the	raw	measured	peptide	ratios	 for	each	protein.	Contaminants	 (as	defined	 in	 the	default	 Maxquant	 list),	 reverse	 identifications,	 and	 proteins	 only	 identified	 by	site	 were	 excluded	 from	 further	 analysis.	 The	 data	 were	 imported	 into	 the	Perseus	 software	 (33)	 for	 assigning	 GO	 annotations,	 and	 pathway	 analysis	 of	m7GTP	 proteins	 showing	 altered	 abundance	 in	 infected	 cells	 was	 performed	using	STRING	v10.0	(34).		Experimental	design	and	Statistical	Rationale	For	 both	 whole	 cell	 lysate	 and	 m7GTP-sepharose	 proteomic	 experiments,	triplicate	 biological	 samples	 were	 used.	 4h	 (Medium	 labeled)	 or	 9h	 (Heavy	labeled)	 post	 infection	 samples	were	 compared	 to	 a	 0h	 (Light	 labeled)	 control	lysate.	SILAC	label	switching	(4h	and	9h	swapped)	was	performed	in	the	second	of	each	set	of	experiments	to	control	for	any	effects	of	the	SILAC	labeling.	Protein	ratios	were	 log2-transformed	and	outliers	removed	by	Grubbs	outlier	detection	implemented	 in	 Graphpad	 prism	 (alpha	 0.1).	 1-way	 ANOVA	was	 performed	 to	calculate	whether	the	abundance	of	a	protein	of	 interest	was	altered	compared	with	a	control	protein	(eIF4E)	with	unaltered	abundance	in	the	assay.			qRT-PCR	
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RNA	 samples	 were	 extracted	 using	 the	 Genelute	 mammalian	 total	 RNA	extraction	 kit	 (Promega)	 and	 qRT-PCR	 analysis	 performed	 by	 the	 SYBR	 green	method	 on	 a	 Viia	 7	 instrument.	 Relative	 quantification	 was	 performed	 by	 the	ΔΔCt	 	 method	 relative	 to	 a	 GAPDH	 standard,	 and	 absolute	 quantification	 was	performed	by	comparing	RNA	copies	to	a	serially	diluted	DNA	standard.			Western	blotting	analysis	Cell	 lysates	 were	 subject	 to	 SDS-PAGE	 electrophoresis	 and	 transferred	 to	nitrocellulose	 membranes	 according	 to	 standard	 protocols.	 Blocking	 and	antibody	incubation	steps	were	performed	in	5%	BSA	or	5%	non-fat	dried	milk	as	 appropriate	 for	 the	 antibody.	 Detection	 was	 performed	 using	 either	 HRP-conjugated	 antibodies	 and	 chemiluminescent	 detection,	 or	 infrared-dye-conjugated	secondary	antibodies	and	detection	on	a	Li-Cor	Odyssey	 imager.	All	densitometry	was	performed	on	 samples	analysed	on	a	Li-Cor	Odyssey	 imager	using	 the	 ImageStudioLite	 software	 (Li-Cor).	 Full	 experimental	 and	 antibody	details	are	given	in	Supplemental	Experimental	Procedures.			Immunofluorescence	microscopy	&	puromycylation	Puromycylation	 was	 performed	 as	 described	 in	 (35).	 In	 brief,	 cells	 grown	 on	glass	 coverslips	 were	 incubated	 for	 5	 minutes	 in	 cell	 culture	 media	supplemented	with	 puromycin	 and	 emetine	 at	 37°C.	 Cells	were	 transferred	 to,	and	maintained	on	ice	for	subsequent	extraction	steps.	Cells	were	incubated	for	2	min	with	permeabilization	buffer.	Cells	were	then	washed	once	with	polysome	buffer,	and	fixed	with	PFA	for	15	min	at	room	temperature.	PFA	was	aspirated,	PBS	 was	 added,	 and	 cells	 were	 maintained	 at	 4°C.	 Subsequent	 antibody	incubations	and	washing	steps	followed	standard	protocols	and	are	described	in	(36).	Imaging	was	performed	on	a	Leica	Sp5	confocal	microscopy	using	a	63x	oil	objective.	 Image	 analysis	 was	 performed	 in	 the	 Leica	 Lita	 software	 (Leica	Microsystems).	Full	details	are	given	in	Supplemental	Experimental	Procedures.		Accession	numbers	The	 mass	 spectrometry	 proteomics	 data	 have	 been	 deposited	 to	 the	ProteomeXchange	 Consortium	 via	 the	 PRIDE	 (37)	 partner	 repository	with	 the	dataset	 identifiers	PXD004984	(whole	cell	SILAC	experiments)	and	PXD004983	(m7GTP	enrichment).		
Results:	Induction	of	the	innate	immune	response	is	a	late	event	in	norovirus	infection	To	examine	the	kinetics	of	the	induction	of	the	innate	response	during	norovirus	infection,	 we	 examined	 the	 levels	 of	 ISG	mRNA	 and	 proteins	 produced	 during	highly	 synchronized	 infection	 of	 immortalized	 macrophage	 cells	 (Fig.	 1B,C).	 A	high	 multiplicity	 of	 infection	 (10	 TCID50	 per	 cell)	 was	 used	 to	 ensure	synchronous	 infection	 and	 the	 infection	 levels	 were	 confirmed	 by	immunofluorescence	staining	(Fig.	S1A).	The	levels	of	representative	ISG	mRNAs,	STAT1,	ISG15	and	viperin,	peaked	at	around	9	hours	post	infection	and	with	the	exception	of	STAT1	remained	at	high	levels	in	infected	cells	(Fig	1D-F).	However,	levels	of	 the	corresponding	 ISG	proteins	did	not	 correlate	with	 this	 increase	 in	RNA	levels,	with	no	observable	induction	of	viperin,	and	no	detectable	increase	in	the	levels	of	ISG15	or	STAT1	(Fig.	1B).			
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	To	 examine	 if	 norovirus	 replication	 affected	 the	 ability	 of	 cells	 to	 respond	 to	interferon	 we	 examined	 the	 effect	 of	 interferon	 treatment	 during	 ongoing	norovirus	 replication	 (Fig.	 2).	 Treating	 infected	 cells	 with	 interferon	 6h	 post-infection	 lead	 to	 robust	 levels	 of	 ISG	mRNA	 induction	whilst	 having	 a	minimal	effect	 on	 MNV	 replication	 (Fig.	 2A-D).	 The	 levels	 of	 ISG	 mRNA	 produced	following	 IFN	 treatment	 of	 infected	 cells	 were	 slightly,	 but	 significantly	(p≤0.001),	decreased	when	compared	 to	uninfected	cells	 (Fig.	2A-D).	However,	despite	 robust	 levels	 of	 ISG	mRNA	 transcription,	 a	 clear	 defect	 in	 ISG	 protein	production	 was	 observed	 in	 norovirus	 infected	 cells	 following	 IFN	 treatment	(Fig.	2E-I).			Norovirus	infection	leads	to	a	translational	bias	To	 examine	 the	 impact	 of	 norovirus	 infection	 on	 global	 cellular	 translation,	de	
novo	 protein	 synthesis	 was	 monitored	 during	 synchronized	 infection	 by	 35S	methionine	pulse-labeling.	 	A	clear	shift	 in	the	translation	profile	was	observed	in	both	RAW264.7	(Fig.	3A)	and	BV-2	(Fig.	3B)	cell	lines	from	9h	post	infection,	though	 this	 fell	 short	 of	 the	 host	 shutoff	 observed	 in	 picornavirus	 or	 feline	calicivirus	infection	(29,	38).	In	line	with	previous	polysome	analysis	performed	on	 norovirus	 infected	 cells	 (14),	 a	modest	 loss	 of	 polysomes	was	 observed	 in	RAW264.7	cells	with	a	corresponding	increase	in	the	80s	monosome	peak	(Fig.	3C).	 A	much	more	 apparent	 reduction	 in	 polysome	 formation	 occurred	 during	norovirus	infection	of	BV-2	cells	(Fig.	3D).	Radio-immunoprecipitation	of	pulse-labeled	 proteins	 from	 norovirus-infected	 cells	 confirmed	 that	 viral	 translation	was	 ongoing	 whilst	 cellular	 translation	 is	 hindered	 at	 12	 hours	 post	 infection	(Fig.	S1B).	MNV	infection	of	BV-2	cells	follows	a	similar	course	to	that	observed	in	 RAW	 264.7	 cells	 (Fig.	 S1C-E).	 The	 loss	 of	 polysomes,	 and	 increase	 in	monosomes,	is	characteristic	of	a	defect	in	translation	initiation	(39).	Under	the	conditions	 used	 40s	 and	 60s	 subunits	 often	 associate	 forming	 RNA-free	 80s	monomers,	 which	 can	 be	 dissociated	 into	 free	 subunits	 under	 high	 salt	conditions,	 whilst	 RNA-associated	 ribosomes	 remain	 intact.	 When	 polysomes	were	 fractionated	under	high	 salt	 conditions	 the	80s	peak	dissociated	 into	40s	and	60s	monomers	confirming	that	the	80s	monomers	were	not	RNA-associated	(Fig.	S2A,B).	A	frequently	observed	mechanism	of	regulating	cellular	translation	inhibition	 during	 viral	 infection	 involves	 the	 phosphorylation	 of	 eIF2α	 (40).	While	 modest	 levels	 of	 eIF2α	 phosphorylation	 were	 observed	 during	 MNV	infection	(Fig.	S2C),	the	kinetics	of	phosphorylation	varied	in	a	cell	type	specific	manner	 and	 had	 a	 poor	 temporal	 association	 with	 the	 observed	 effect	 on	 the	translation	profile,	 particularly	 in	BV-2	 cells.	 Based	on	 these	observations,	 and	that	 eIF2α	 phosphorylation	 would	 also	 be	 anticipated	 to	 be	 inhibitory	 for	norovirus	 translation,	which	was	not	 in	evidence,	we	concluded	 that	under	 the	experimental	 conditions	used	here,	eIF2α	phosphorylation	did	not	 significantly	contribute	 to	 the	 translational	 bias	 observed	 during	 infection.	 Studies	 on	 pox	virus	 infected	 cells	 have	 suggested	 that	 the	 sequestration	 of	 sites	 of	 active	translation	 to	 centers	of	 virus	 replication	 causes	 a	 translational	bias	 (35).	This	possibility	 was	 investigated	 using	 puromycylation	 to	 visualize	 active	 sites	 of	protein	 synthesis	 by	 covalent	 linkage	 of	 puromycin	 to	 newly	 synthesized	peptides	 as	 described	 (35).	 Puromycylation	 of	 mock	 or	 infected	 BV-2	 cells	showed	some	enrichment	of	sites	of	active	translation	co-localising	with	sites	of	
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viral	 RNA	 replication	 as	 determined	 by	 staining	 for	 dsRNA	 (Fig.	 3E).	 However	this	enrichment	 fell	short	of	 the	sequestration	observed	with	vaccinia	 infection	(35)	 with	 the	 majority	 of	 active	 translation	 localizing	 outside	 of	 the	 viral	replication	complexes.		Quantitative	 proteomic	 analysis	 of	 MNV-infected	 cells	 and	 m7GTP-binding	complexes	reveals	modifications	to	the	eIF	complex	We	 have	 previously	 described	 the	 novel	 mechanism	 of	 protein-primed	 VPg-dependent	 translation	 used	 by	 caliciviruses	 (5–7,	 12).	 Given	 the	 variation	between	 the	 initiation	 factor	 requirements	 for	 host-cell	 mRNA	 and	 viral	 VPg-dependent	 RNA	 translation,	 a	 quantitative	 proteomics	 approach	 was	 used	 to	investigate	changes	to	both	the	 level	of	relevant	translation	initiation	factors	 in	the	 host	 cell,	 as	 well	 as	 their	 ability	 to	 incorporate	 into	 the	 eIF	 complex	 at	different	times	post	infection.	Using	a	stable	isotope	labeling	approach	(41–43),	cells	 were	 labeled	with	 light,	 medium	 or	 heavy	 stable	 isotope	 of	 arginine	 and	lysine.	Whole	cell	 lysates	were	prepared	from	either	mock	or	infected	cells	at	4	and	 9	 hours	 post	 infection	 and	 these	 samples	 used	 to	 determine	 the	 level	 of	initiation	 factors	 within	 the	 cell.	 At	 the	 same	 time	 a	 m7GTP-sepharose	enrichment	 was	 performed	 to	 determine	 the	 effect	 of	 viral	 infection	 on	 the	composition	 of	 eIF4E-containing	 cap-binding	 complexes	 (Fig.	 4A).	Representative	Coomassie	staining		(Fig.	4B)	and	western	blot	analysis	(Fig.	4C)	of	 the	 purified	 complex	 confirmed	 the	 enrichment	 of	 translation	 initiation	factors,	as	well	as	recruitment	of	the	viral	VPg	protein	and	loss	of	a	marker	for	soluble	cytoplasmic	proteins	(GAPDH).		Mass	spectrometry	analysis	of	independent	biological	replicates	of	the	whole	cell	lysates	 identified	 3466	 proteins	 with	 two	 or	 more	 peptides	 (Fig	 4D).	 As	anticipated,	 the	 strategy	 used	 to	 enrich	 the	 eIF	 complex	 resulted	 in	 fewer	proteins	 being	 identified	 across	 the	 three	 replicates	 (535),	 however	 a	 better	overlap	in	the	proteins	quantified	across	the	replicates	(Fig	4E).	 	Gene	ontology	analysis	 (Table	S1)	of	 the	m7GTP-sepharose	purified	 samples	performed	using	STRING	(34)	revealed	that	proteins	showing	an	arbitrary	≥2-fold	change	in	their	abundance	at	9h	post-infection	were	associated	with	translation	(p=4.9-55)	with	changes	 to	 the	 ribosomal	 subunits	 and	 the	 eIF3	 complex	 being	 particularly	significant	(p=6.76E-28	to	1.05E-46).	GO	annotation	of	both	datasets	in	Perseus	revealed	 that	 the	 m7GTP	 dataset	 was	 enriched	 for	 proteins	 with	 GO	 terms	including	 the	 string	 ‘translation’	 (13.6%	 vs	 3.8%).	 The	 complete	 proteomics	dataset	obtained	from	the	analysis	of	both	the	whole	cell	lysate	and	the	m7GTP-enriched	complex	is	provided	in	tables	S2	and	S3.	Notably,	all	viral	proteins	were	identified	 in	 the	 whole	 cell	 dataset,	 and	 all	 but	 NS4	 in	 the	 m7GTP	 dataset,	including	the	VF-1	protein/ORF4	alternative	reading	frame	product.		Alterations	to	 individual	eIF	components	were	assessed	with	no	changes	 in	the	abundance	 of	 eIF4E	 within	 infected	 cells,	 or	 in	 its	 ability	 to	 bind	 to	 m7GTP-sepharose	 being	 observed	 (Fig.	 5A).	However	 changes	 to	 other	 components	 of	the	eIF4F	complex	were	apparent.	Reduced	levels	of	the	eIF4AII	but	not	eIF4AI	isoform	 of	 eIF4A	 were	 apparent	 at	 late	 time	 points	 in	 cells	 and	 in	 m7GTP-purified	 complexes	 (Fig.	 5B).	 Another	 helicase,	 eIF4B,	 showed	 similar	 levels	within	 whole	 cell	 lysates	 at	 late	 times	 post-infection,	 but	 was	 reduced	 within	
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m7GTP-purified	complexes	(Fig.	5C).	 Isoform-specific	variation	in	the	impact	of	infection	on	eIF4G	levels	was	also	observed	with	several	isoforms	showing	slight,	but	 not	 significant	 reductions	 in	 cellular	 abundance	 and	 all	 isoforms	 showing	reduced	m7GTP-sepharose	binding,	though	only	the	loss	of	Dap5	was	significant	(Fig.	 5D).	 Please	 note	 that	 due	 to	 inconsistency	 with	 eIF4GII	 and	 Dap5	nomenclature,	 in	 this	 manuscript	 eIF4GII	 (eIF4G3)	 is	 used	 to	 refer	 to	 the	~170kDa	 long	 form,	 and	Dap5	 (eIF4G2)	 is	used	 to	 refer	 to	 the	~100kDa	 short	form	 also	 known	 as	 NAT1.	 As	 a	 component	 of	 the	 core	 of	 the	 eIF4F	 complex,	eIF4G	 interacts	with	 the	 small	 ribosomal	 subunit	 via	 the	 eIF3	 complex,	 which	was	 detected	 in	 its	 entirety	 in	 both	 the	 whole	 cell	 lysate	 and	 in	 the	 m7GTP-associated	 complex	 (Fig.	 5E,F).	 The	 abundance	 of	 eIF3	 components	 remained	largely	 unaffected	 during	 infection	 (Fig.	 5E),	 however	 at	 9h	 post	 infection	 the	ability	 of	 eIF4F	 to	 recruit	 the	 eIF3	 complex	was	 greatly	 diminished,	 consistent	with	the	gene	ontology	analysis	(Fig.	5F).	Other	proteins	recruited	to	the	eIF4F	complex	 by	 eIF3	 also	 showed	 a	 similarly	 reduced	 ability	 to	 bind	 m7GTP-sepharose	 and	 are	 detailed	 in	 figure	 S3A-D.	 Western	 blot	 analysis	 of	 eIF4E-containing	 complexes	 by	 m7GTP-sepharose	 enrichment	 from	 infected	 cells	confirmed	 the	 loss	 of	 eIF3D	 and	 eIF4GII,	 as	well	 as	 the	 impact	 of	 infection	 on	eIF4AII	 expression	 (Fig.	 S3E).	 Whilst	 large	 number	 of	 proteins	 showed	 either	unaltered	 or	 decreased	 binding	 to	 m7GTP	 at	 late	 times	 post-infection,	 few	showed	 increased	 binding,	 with	 viral	 proteins	 representing	 the	 primary	exception	 to	 this	 pattern.	 All	 viral	 proteins	 except	 NS4	 showed	 enrichment	 to	some	extent	including	VPg	and	the	protease	NS6.	Given	the	previous	associations	of	 3C-like	 proteases	 in	mediating	 virus-induced	 shutoff	 of	 host	 translation	 via	cleavage	of	 initiation	 factors,	 the	presence	of	 the	viral	protease	NS6	 in	samples	enriched	 for	 initiation	 factors	 suggested	 a	 similar	 mechanism	 could	 be	responsible	for	the	alterations	to	initiation	factor	complexes	observed	here.		The	 norovirus	 protease	 (NS6)	 contributes	 to	 translational	 inhibition	 via	 PABP	cleavage	Previous	studies	with	feline	calicivirus	(FCV)	or	recombinant	norovirus	protease	suggested	a	potential	role	 for	 the	calicivirus	3C-like	protease	 in	 the	cleavage	of	PABP	 (29).	 The	 biological	 consequence	 of	 the	 norovirus	 protease-mediated	cleavage	was	not	examined	due	to	the	lack	of	an	available	cell	culture	system	at	the	time	the	study	was	undertaken.	PABP	was	identified	in	both	whole	cell	lysate	and	m7GTP	 samples,	 however	 its	 abundance	 was	 largely	 unmodified.	 Notably	only	a	small	fraction	of	PABP	cleavage	has	been	shown	to	be	required	for	effects	on	host	cell	translation	(44).	To	determine	if	the	MNV	NS6	protease	identified	in	the	m7GTP	analysis	contributed	to	the	loss	of	eIFs	from	the	eIF4F	complex,	the	ability	of	NS6	to	cleave	initiation	factors	was	examined.	Expression	of	a	GFP-NS6	fusion	 protein	 resulted	 in	 the	 cleavage	 of	 PABP,	whilst	 other	 initiation	 factors	known	 to	be	 targets	of	other	3C	or	3C-like	proteases	 remained	uncleaved	 (Fig.	6B)	(45).	Side-by-side	comparison	of	the	cleavage	products	of	PABP	from	293T	cells	 expressing	 the	MNV	 receptor	 (CD300lf,	 (46,	 47))	 and	 either	 the	 protease	alone,	or	infected	with	MNV	reveals	that	this	cleavage	product	can	be	observed	in	infected	 cells,	 though	 additional	 cleavage	 products	 are	 also	 present	 (Fig.	 S4A).	Analysis	 of	 time-course	 samples	 from	 infected	 cells	 shows	 the	 appearance	 of	cleavage	 products	 from	 9h	 post-infection,	 consistent	 with	 the	 timing	 of	 the	impact	on	cellular	translation	(Fig.	6C).	Not	all	of	the	PABP	detected	by	western	
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blot	was	cleaved	during	 infection,	 in	agreement	with	previous	observations	 for	other	 positive	 sense	RNA	 viruses	where	 cleavage	 of	 a	 fraction	 of	 PABP	has	 an	impact	 on	 cellular	 translation	 (44).	 The	 anti-PABP	 antibody	 used	 to	 examine	cleavage	during	 infection	detects	 both	PABP1	 and	PABP3,	 therefore	 it	was	not	possible	to	distinguish	if	 the	partial	cleavage	observed	by	western	blot	was	the	result	 of	 an	 isoform	 specific	 effect	 of	 NS6.	 The	 expression	 of	 NS6	 alone	 was	sufficient	 to	 have	 a	 small	 but	 reproducible	 and	 significant	 impact	 on	 cellular	translation	 in	 the	 absence	 of	 viral	 replication	 (Fig.	 6D),	 without	 any	 obvious	impact	 on	 cellular	 viability	 (Fig.	 S4B).	 Expression	 of	 NS6	 alone	 in	 mock-	 or	interferon-treated	 cells	 confirmed	 that	 NS6	 expression	 alone	 was	 at	 least	partially	 responsible	 for	 the	 reduced	 translation	 of	 induced	 ISGs	 (Fig.	 S5B,C).	PABP	 consists	 of	 an	 N-terminal	 region	 containing	 multiple	 RNA	 recognition	motifs	and	the	eIF4G-binding	site,	and	a	C-terminal	region	containing	the	PABC-domain	(Fig.	6A).	Many	viruses	target	the	flexible	linker	region	connecting	these	two	 domains	 (48).	 Mutational	 analysis	 was	 used	 to	 demonstrate	 that	 the	 NS6	protease	 cleavage	 site	was	Q440,	 also	 known	 as	 the	 3Calt’	 site	 (Fig.	 S5A).	 The	biological	 consequence	 of	 PABP	 cleavage	 and	 the	 impact	 of	 cleavage	 on	 virus	replication	 was	 examined	 by	 overexpressing	 either	 wild-type	 PABP	 or	 a	 non-cleavable	 (Q440A)	 form	of	 PABP	 in	MNV	permissive	 cells.	 The	 expression	 of	 a	non-cleavable	form	of	PABP	resulted	in	the	partial	restoration	of	ISG	translation	during	 infection	 (Fig.	 7A)	 as	 low-levels	 of	 viperin	 induction	 was	 seen	 during	infection.	 This	 partial	 restoration	 of	 ISG	 induction	 also	 resulted	 in	 a	 delayed	replication	 during	 low	multiplicity,	multicycle	 replication	 typically	 causing	 a	 1	log10	reduction	in	viral	titres	at	18h	post-infection	(Fig.	7B,C).			To	 investigate	whether	 infection	or	cleavage	of	PABP	in	 infected	cells	 impacted	on	PABP	localization,	confocal	microsocopy	was	used	to	examine	the	localization	of	 PABP	 in	 infected	 cells.	 Both	 mock	 and	 infected	 cells	 possessed	 diffuse	cytoplasmic	 PABP	 localization,	 with	 no	 evidence	 of	 altered	 localization	 in	response	 to	 MNV-infection	 apparent	 (Fig.	 S6A).	 Attempts	 were	 made	 to	 use	CRISPR-mediated	 gene	 editing	 to	 generate	 MNV	 permissive	 cells	 expressing	 a	non-cleavable	 form	of	PABPC1	(Fig	S6B),	however	all	clones	 that	were	 isolated	were	 heterozygous	 for	 a	 PABP	 C-terminal	 deletion	 (all	 clones	 possessed	 a	frameshift	 at	 P433,	 resulting	 in	 a	 truncation	 20	 amino	 acids	 later)	 (Fig	 S6C).	When	 not	 infected,	 cell	 viability	 (Fig.	 S6D)	 and	 translation	 (Fig.	 S6E)	 in	 these	cells	remained	unaffected.	Upon	infection,	an	approximate	100-fold	drop	in	viral	titres	at	18h	post-infection	was	observed	in	cells	containing	the	truncated	form	of	PABP	(Fig.	7D).	These	data	demonstrate	a	role	for	NS6	cleavage	of	PABP	in	at	least	partially	reducing	cellular	translation	in	infected	cells.		To	examine	if	NS6-mediated	cleavage	of	PABP	also	resulted	in	the	observed	loss	of	eIF3	from	the	eIF4F	complex	the	effect	of	NS6	cleavage	on	the	recruitment	of	eIF3	to	the	eIF4F	complex	was	examined	by	the	enrichment	of	the	eIF4F	complex	on	m7GTP-sepharose.	 	The	recruitment	of	eIF3D	to	 the	eIF4F	complex	was	not	affected	 by	 PABP	 cleavage,	 yet	 both	 full	 length	 and	 the	 N-terminal	 cleavage	products	 of	 PABP	were	 recruited	 to	 the	 eIF4F	 complex	 (Fig.	 S5D).	 These	 data	suggested	 that	 whilst	 NS6-mediated	 PABP	 cleavage	 plays	 a	 partial	 role	 in	reducing	 cellular	 translation	 in	 MNV-infected	 cells,	 other	 pathways	 also	contribute.	 One	 possible	 explanation	 would	 be	 the	 triggering	 of	 apoptosis,	
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previously	 described	 as	 being	 induced	 by	 MNV	 infection	 (49),	 which	 could	explain	the	additional	cleavage	products	of	PABP	in	infected	cells	(e.g.	Fig.	6C	and	S4A)	as	PABP	is	known	to	be	cleaved	during	apoptosis	(50).			Loss	of	eIF3	recruitment	to	translation	initiation	complexes	is	part	of	the	cellular	response	to	infection	Apoptosis	is	a	key	cellular	pathway	known	to	inhibit	translation	initiation	(30).	MNV	 infection	 causes	 the	 induction	 of	 apoptosis	 through	 downregulation	 of	survivin	 (51)	 leading	 to	 the	 activation	 of	 a	 number	 of	 caspases	 as	 well	 as	cathepsin	 B	 (52).	 The	 eIF4GI	 and	 II	 proteins	 are	 targets	 for	 caspase-mediated	cleavage	at	multiple	positions	as	shown	in	Fig.	8A	(30).	The	SILAC	quantification	presented	 in	Fig	4	represents	an	averaged	fold-change	across	all	 the	quantified	peptides	from	an	individual	protein.	In	the	case	of	eIF4GI,	over	60	peptides	from	this	protein	were	identified	in	the	m7GTP-sepharose	purified	samples	across	the	entire	 protein,	 enabling	 the	 direct	 identification	 of	 eIF4G	 fragments	 that	 may	remain	 associated	 with	 the	 eIF4F	 complex	 if	 caspase	 cleavage	 had	 occurred.	Caspase	cleavage	of	eIF4GI	results	in	the	production	of	three	fragments,	of	which	only	the	middle	fragment	(M-FAG)	would	be	expected	to	bind	efficiently	to	m7-GTP	 sepharose.	 Differing	 amounts	 of	 the	 N-FAG,	 M-FAG	 and	 C-FAG	 fragments	were	 found	 associated	 with	 the	 eIF4F	 complex	 at	 9	 hours	 post	 infection,	consistent	with	 caspase-mediated	 cleavage	 resulting	 in	 the	 preferential	 loss	 of	fragments	that	do	not	interact	directly	with	eIF4E	(Fig.	8B).	Retention	of	N-FAG	could	 be	 explained	 as	 an	 indirect	 interaction	mediated	 through	 PABP	 and	 the	mRNA.	 To	 examine	 the	 correlation	 between	 induction	 of	 apoptosis	 and	 the	impact	 of	 infection	 on	 cellular	 translation,	 the	 activation	 of	 caspase	 3,	 the	cleavage	 of	 PARP,	 eIF4GI	 and	 eIF4GII	 was	 examined	 by	western	 blot.	 In	 BV-2	cells,	 loss	of	 full-length	eIF4GI	and	 II	and	 the	appearance	of	prominent	eIF4GII	cleavage	products	were	apparent	 from	9h	post-infection,	 concomitant	with	 the	appearance	of	cleaved-caspase	3	and	PARP	(Fig.	8C).	Loss	of	the	cellular	marker	GAPDH	was	also	 seen	at	 late	 times,	 corresponds	 to	a	 reduction	 in	 cell	 viability	(Fig.	 S7).	 In	 contrast,	 during	 replication	 in	 RAW	 264.7	 cells	 the	 induction	 of	apoptosis	 was	 less	 pronounced	 and	 somewhat	 delayed	 in	 agreement	 with	previous	observations	(11,	49,	51)	with	only	low	levels	of	cleaved	caspase	being	detected	 and	 incomplete	 cleavage	 of	 PARP	 (Fig.	 8D).	 The	 marked	 cleavage	 of	eIF4GI	 and	 II	 was	 also	 not	 readily	 observed.	 Cleaved	 caspase	 3	 and	 PARP	cleavage	 were	 observed	 from	 9h	 post-infection,	 however	 unlike	 in	 BV-2	 cells,	levels	 of	 cleaved	 caspase	 3	 remained	 low,	 and	 PARP	 cleavage	 did	 not	 reach	completion.	 Whilst	 the	 contribution	 of	 individual	 caspases	 can	 vary,	 efficient	PARP	cleavage	 is	a	hallmark	of	apoptotic	 cell	death.	 Incomplete	PARP	cleavage	has	 been	 previously	 linked	 to	 accelerated	 cell	 death	 through	 a	 combination	 of	apoptosis	and	necroptosis	and	 linked	 to	 low	 intracellular	ATP	and	NAD+	 levels	(53).	 	 This	suggests	 that	 cell	 death	 in	 RAW264.7	 cells	 may	 not	 be	 exclusively	apoptotic	 and	 offers	 an	 explanation	 as	 to	why	 the	 apoptotic	 phenotype	 is	 less	pronounced	in	these	cells.				To	determine	if	the	cleavage	of	eIF4GI	and	II	during	MNV	infection	was	the	result	of	apoptosis,	the	effect	of	the	pan-caspase	inhibitor	z-vad-fmk	on	eIF4G	cleavage	was	 examined.	 As	 previous	 studies	 have	 indicated	 that	 the	 inhibition	 of	apoptosis	 in	 BV-2	 cells	 results	 in	 rapid	 induction	 of	 necroptosis	 (54),	 the	
	12	
necroptosis	 inhibitor	 necrostatin-1	 was	 included	 where	 noted.	 eIF4GI	 and	 II	levels	were	restored	by	the	 inhibition	of	caspases	 in	a	dose-dependent	manner	which	 also	 correlated	 with	 a	 partial	 restoration	 of	 translation	 of	 the	representative	ISGs	(Fig.	8E).	The	impact	of	infection	on	the	cellular	translation	profile	of	cells	was	also	partially	restored	when	apoptosis	was	inhibited	(Fig.	8F),	whilst	 this	 effect	 was	 slight,	 quantification	 of	 repeat	 samples	 by	phosphorimaging	 revealed	 it	 was	 significant	 (Fig.	 8G).	 	 Furthermore,	 the	inhibition	 of	 apoptosis	 and	 the	 resulting	 increase	 in	 the	 translation	 of	 induced	ISG	mRNAs	 lead	 to	 delayed	 replication	 kinetics	 during	 a	multicycle	 replication	experiment	(Fig.	8H).			
Discussion:	As	obligate	intracellular	pathogens,	viruses	must	replicate	within	host	cells	and	must	therefore	balance	the	use	of	host	resources	and	the	ability	to	evade/control	the	cellular	response	to	infection.	In	this	study	we	demonstrate	that	noroviruses	alter	cellular	translation	through	the	modification	of	translation	initiation	factors	to	 not	 only	 favour	 viral	 translation	 but	 also	 impede	 the	 translation	 of	 genes	induced	as	a	result	of	the	innate	immune	response.	This	offers	a	new	mechanism	by	which	norovirus	 is	 able	 to	 regulate	 the	 immune	 response,	 and	demonstrate	that	 by	 modifying	 translation	 in	 infected	 cells,	 noroviruses	 are	 capable	 of	preventing	production	of	ISGs	such	as	STAT1	and	ISG15	known	to	be	important	for	control	of	norovirus	infection	(17,	55).	
	In	the	current	study	we	observed	that	PABP	cleavage	by	the	norovirus	protease	plays	a	role	in	modification	of	host	translation	and	can	impact	on	the	translation	of	induced	ISGs.	PABP	cleavage	has	also	been	observed	following	infection	with	a	range	of	viruses	 including	other	caliciviruses	(29),	picornaviruses,	HIV	(56,	57)	and	 others	 (48).	 The	 actual	 mechanism	 by	 which	 PABP	 cleavage	 inhibits	 or	modifies	cellular	 translation	remains	unclear.	PABP	plays	multiple	 roles	within	the	cell;	cytoplasmic	PABP	is	involved	in	translation	enhancement	via	a	bridging	interaction	with	eIF4G	leading	to	a	“closed	loop”	conformation	of	the	RNA	which	in	 turns	 is	 believed	 to	 increase	 RNA	 stability	 and	 promote	 ribosome	 recycling	(58).	 Through	 additional	 interactions	 with	 the	 ribosomal	 release	 factor	 eRF3,	PABP	is	also	believed	to	play	a	role	in	translation	termination	contributing	to	the	control	 of	 nonsense-mediated	 mRNA	 decay	 (59,	 60).	 Whilst	 early	 research	hypothesized	 that	 cleavage	 would	 prevent	 mRNA	 circularization	 (61),	 more	recent	 data	 suggests	 that	 the	 N-terminal	 region	 of	 PABP	 is	 necessary	 and	sufficient	 for	 both	 poly(A)	 and	 eIF4G-binding	 (62).	 	 The	 cleavage	 of	 PABP	 by	picornaviruses	is	also	incomplete	and	targets	polysome	associated	PABP	(29,	62,	63)	 indicating	 the	 protease	 targets	 only	 a	 subset	 of	 PABP	 molecules.	 The	 C-terminus	 of	 PABP	 is	 required	 for	 binding	 of	 a	 number	 of	 protein	 partners	including	PAIP1	and	2,	 and	eRF3	 (64,	65).	 It	 is	 likely	 that	 cleavage	 inhibits	 the	recruitment	of	 these	proteins	 to	 actively	 translating	mRNA,	 leading	 to	 reduced	ribosome	 release	 and	 recycling	 of	 subunits	 (62).	 The	 norovirus	 NS6-mediated	cleavage	 removes	 the	 C-terminal	 oligomerization	 domain,	which	 could	 act	 in	 a	dominant	manner	to	prevent	the	extension	of	PABP	oligomers	on	the	polyA	tail	of	cellular	(or	viral)	mRNA	(66).	However	the	impact	of	limited	PABP	cleavage	on	the	oligomerization	of	PABP	on	the	poly	A	tail	is	yet	to	be	fully	explored.	Of	note,	our	data	from	heterozygous	CRISPR-modified	cells	show	that	a	mixed	population	
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of	full	length	PABP	and	the	C-terminally	truncated	PABP	fragment	are	sufficient	for	growth	and	normal	levels	of	translation	in	unstressed/uninfected	cells.	This	suggests	 that	 partial	 recruitment	 of	 PABP-binding	 proteins	 to	 polysomes	 is	sufficient	for	normal	protein	synthesis,	however	more	complete	loss	is	inhibitory	(Fig.	9B).		Caspase-mediated	 cleavage	 of	 initiation	 factors	 has	multiple	 effects	 on	 cellular	translation	(67,	68)(69).	In	the	case	of	eIF4GI,	cleavage	causes	the	linearization	of	the	mRNA	as	the	PABP-binding	N-FAG	fragment	of	eIF4GI	and	the	middle	M-FAG	 fragment	 containing	 the	 eIF4E	 and	 eIF3-binding	 sites	 are	 separated	following	 cleavage	 (Fig.	 9C).	 Apoptotic	 translation	 shutoff	 correlates	 with	cleavage	of	eIF4GII	where	additional	caspase	target	sites	further	degrade	eIF4GII	and	 separate	 the	 eIF4E	 and	 eIF3	 binding	 sites	 preventing	 recruitment	 of	 the	mRNA	 to	43s	 subunits	 (Fig.	 9D)	 (69).	Of	 note,	 VPg-dependent	 viral	 translation	appears	 to	 continue	 even	 after	 apoptotic	 cleavage	 of	 eIF4G	 has	 initiated	 (Fig.	3,8).	This	is	consistent	with	recent	data	on	VPg-dependent	translation	where	the	middle	 fragment	 of	 eIF4G	 is	 sufficient	 for	 norovirus	 translation	 (4,	 6).	 The	importance	 of	 this	 late	 viral	 translation	 for	 virus	 biology	 remains	 to	 be	determined.		The	 mass	 spectrometry	 results	 successfully	 identified	 modification	 consistent	with	caspase-cleavage	of	eIF4G,	but	also	yielded	further	details	on	alterations	to	the	 eIF	 complex,	 including	 diminished	 eIF4AII,	 but	 not	 eIF4AI	 levels,	 and	alterations	to	eIF4B	binding.	Particularly	in	the	case	of	eIF4AII,	there	have	been	conflicting	 reports	 that	 this	 specific	 form	 of	 eIF4A	 is	 vital	 for	 microRNA-mediated	translation	inhibition	(70,	71).	Whether	the	loss	of	eIF4AII	is	due	to	the	viral	or	host	response	merits	further	investigation.	This	work	represents	the	first	use	of	SILAC-based	quantitative	proteomics	to	study	norovirus	infection	or	virus-mediated	 translation	 inhibition.	 Furthermore,	 this	 study	 makes	 clear	 that	quantitative	 proteomics	 is	 capable	 of	 offering	 up	 a	 new	 level	 of	 detail	 with	regards	 to	 identifying	 the	 roles	 and	 responses	 of	 individual	 eIF	 components	under	 stress	 conditions,	 and	 their	 contribution	 to	 the	 translation	 efficiency	 of	individual	mRNAs.		Other	 viruses	 have	 been	 shown	 to	 modify	 eIF	 components	 in	 order	 to	 alter	cellular	translation	(16).	One	example	would	be	African	Swine	Fever	Virus	which	utilizes	 both	 eIF4E	 phosphorylation	 and	 redistribution	 of	 the	 translational	machinery	to	viral	factories	in	order	to	control	host	translation	and	the	immune	response	(72).	However,	the	best	characterized	example	of	eIF4F	modification	is	from	 the	 picornaviruses	 which	 utilize	 two	 viral	 proteases	 to	 create	 a	environment	 where	 host	 translation	 is	 completely	 inhibited	 (38).	 	 The	 effects	observed	in	norovirus-infected	cells	 in	many	ways	resemble	those	generated	in	picornavirus	 infection,	 however	 there	 are	 important	 distinctions.	 Firstly,	 the	scale	of	inhibition	seen	is	clearly	different	with	picornaviruses	causing	complete	host	shutoff,	whilst	noroviruses	merely	cause	a	reduction	of	host	translation	(Fig.	3).	 Secondly,	 shutoff	 in	 picornavirus	 infection	 is	 an	 early	 event	 and	 allows	 the	exclusive	 use	 of	 host	 translation	 apparatus	 for	 efficient	 viral	 translation	 (38),	whereas	in	norovirus	infection,	altered	translation	is	a	relatively	 late	event	and	comes	at	a	time	when	viral	replication	appears	largely	complete	(Fig.	1,3).	Whilst	
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the	shutoff	observed	 in	picornaviruses	would	also	 inhibit	production	of	 ISGs	 in	response	to	infection,	in	norovirus	infection	this	would	appear	to	be	the	primary	effect	 of	 reduced	 cellular	 translation	 at	 this	 time	 during	 infection	 (Fig.	 2,3).	 A	final	 distinction	 is	 in	 the	 mechanism	 of	 inhibition,	 with	 picornavirus	 shutoff	driven	entirely	by	two	viral	proteases	(2A,	3C)	that	are	necessary	and	sufficient	for	 the	 observed	 phenotype.	 In	 contrast	 norovirus	 utilizes	 just	 a	 single	 viral	protease	 -	 NS6,	 a	 3C-like	 protease	 that,	 of	 the	 initiation	 factors	 tested,	 cleaves	only	PABP	(Fig.	6).	However,	norovirus	 infection	 is	 capable	of	 inducing	 further	alterations	to	translation	initiation	by	utilizing	the	induction	of	apoptosis	and	in	particular,	 caspase	 activation	 in	 order	 to	 mimic	 the	 effects	 of	 2A	 protease	cleavage	 on	 eIF4G	 (Fig.	 8)(73).	Whilst	 apoptosis	 is	 also	 induced	 in	 poliovirus-infected	cells,	the	contribution	of	this	to	eIF4G	cleavage	is	unclear	(74).	The	cells	used	in	this	study	are	macrophage	or	microglia-like	cell	lines,	and	in	the	infected	host	the	virus	is	known	to	be	able	to	infect	dendritic	cells	and	macrophages	(75),	and	 most	 recently,	 B	 cells	 (76).	 Whilst	 the	 pro-viral	 nature	 of	 the	 apoptotic	response	in	norovirus	infection	has	been	discussed	previously,	it	is	possible	that	this	 mechanism	 plays	 a	 role	 in	 a	 subset	 of	 infected	 cells	 within	 the	 host.	 Of	particular	 note	 is	 the	 recent	 finding	 that	 enteric	 bacteria	 may	 also	 be	 able	 to	modify	 this	 response,	 with	 Salmonella	 co-infection	 inhibiting	 MNV-induced	apoptosis,	 diminishing	 viral	 replication	 and	 notably	 also	 increasing	 cytokine	levels	 produced	 in	 response	 to	 infection	 (77),	 fitting	with	 our	 hypothesis	 that	apoptosis	is	used	by	noroviruses	as	a	mechanism	to	suppress	the	translation	of	induced	ISGs.		In	 summary	 this	 study	 demonstrates	 than	 norovirus	 infection	 modifies	 the	ability	of	host	cells	to	respond	to	infection	by	limiting	the	translation	of	induced	mRNAs.	The	alterations	to	host	translation	observed	are	induced	both	directly	by	the	virus,	as	well	as	through	the	induction	of	apoptosis,	and	serve	to	counter	the	paracrine	impact	of	the	innate	response.		
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Figure	legends:	
Figure	 1.	 A	 defect	 in	 ISG	 protein	 synthesis,	 but	 not	 mRNA	 induction	 is	
observed	 during	 norovirus	 infection.	A)	Genome	schematic	of	 the	norovirus	genome	 with	 the	 four	 previously	 described	 murine	 norovirus	 open	 reading	
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frames	 are	 shown	 (11).	 The	 NS1/2-7	 nomenclature	 for	 the	 mature	 peptides	generated	from	ORF1	(described	in	(8))	is	used	throughout.	B)	Western	blot	for	the	norovirus	NS7	non-structural	protein	and	the	ISGs	STAT1,	ISG15	and	viperin.	C)	qRT-PCR	for	Norovirus	genomic	RNA		and	(D-F)	for	the	ISGs	STAT1,	ISG15	and	viperin.	 The	 samples	 for	 panels	 B-F	 were	 taken	 from	 a	 high	 multiplicity	 of	infection	(MOI:	10	TDIC50/cell)	timecourse	performed	in	RAW	264.7.	The	correct	position	 for	viperin	 is	 indicated	with	 ‘<’	and	 is	 immediately	beneath	the	visible	non-specific	 band.	 For	 qRT-PCR	 n	 ≥	 3,	 and	 error	 bars	 represent	 standard	deviation.		
Figure	 2.	 MNV	 infected	 cells	 respond	 to	 interferon	 at	 the	 transcriptional	
but	 not	 post-transcriptional	 level.	 Samples	were	harvested	 from	RAW	264.7	cells,	 infected	 at	 high	 MOI	 (10),	 18h	 post-infection	 following	 treatment	 with	interferon	 or	mock	 culture	 supernatant.	 qRT-PCR	 of	 norovirus	 and	 ISG	mRNA	levels	following	interferon	treatment	(A-D)		and	representative	western	blots	are	shown	in	E),	with	densitometry	analysis	of	protein	levels	in	F-I)	Error	bars	show	standard	 deviation,	 N	 =	 3.	 Data	 are	 presented	 relative	 to	 a	 mock,	 untreated	control.	 Statistical	 analysis	 was	 performed	 by	 one-way	 ANOVA,	 with	 the	exception	 of	 figure	 F)	which	was	 performed	 by	 t-test.	 For	 qRT-PCR,	 statistical	analysis	 was	 performed	 on	 the	 untransformed	 ΔΔCt	 data.	 (*=<0.05,	 **=<0.01,	***=<0.001,	****=<0.0001).	
	
Figure	3.	Norovirus	infection	alters	the	translational	profile	of	the	host	cell.	A)	RAW	264.7	or	B)	BV-2	 cells	 infected	at	 an	MOI	of	10	TCID50/cell	with	MNV	were	 pulse	 labeled	 for	 1h	 at	 the	 indicated	 timepoints	 and	 imaged	 on	 a	phosphorimager.	Polysome	profiling	of	 infected	C)	RAW	264.7	or	D)	BV-2	cells	was	 performed.	 E)	 Puromycylation	 analysis	 of	 infected	BV-2	 cells	 shows	 some	minor	enrichment	of	sites	of	active	translation	co-localising	with	viral	replication	complexes	visualized	using	anti-dsRNA.	
	
Figure	 4.	 Quantitative	 proteomic	 analysis	 of	 translation	 initiation	 during	
MNV	 infection.	 SILAC-based	 quantitative	 proteomics	 was	 employed	 to	investigate	 changes	 to	 eIF	 composition	during	high	MOI	 (10)	MNV	 infection	of	BV-2	 cells.	 The	 experimental	 layout	 is	 illustrated	 in	 A)	 with	 samples	 taken	 at	mock	 (0h)	 early	 (4h)	 or	 late	 (9h)	 post-infection	 either	 lysed	 or	 subject	 to	m7GTP-sepharose	purification.	A	Coomassie	gel	(B)	and	representative	western	blots	 (C)	 confirm	 initiation	 factor	 enrichment.	 Venn	 diagrams	 illustrating	experimental	proteome	coverage	in	D)	whole	cell	lysate,	or	E)	m7GTP-sepharose	pulldowns.	
	
Figure	5.	Norovirus	infection	alters	the	abundance	and	eIF4F	association	of	
cellular	 translation	 initiation	 factors.	Mass	 spectrometry	data	 for	 individual	eIF	 components	 identified	 in	 the	 whole	 cell	 (WCL)	 or	 m7GTP-sepharose	(m7GTP)	experiments	are	shown,	including	A)	eIF4E,	B)	eIF4A,	C)	eIF4B	and	D)	eIF4G.	The	whole	eIF3	complex	was	successfully	identified	by	mass	spectrometry	and	 its	 relative	 abundance	 in	 E)	 WCL	 or	 F)	 m7GTP	 samples	 is	 shown.	Significance	was	tested	by	1-way	ANOVA	comparing	changes	to	a	control	protein	with	unaltered	abundance	(eIF4E).	Changes	in	eIF4E	levels	were	determined	by	comparing	 its	 4h	 and	 9h	 levels.	 Error	 bars	 represent	 standard	 deviation,		
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*=<0.05,	**=<0.01,	***=<0.001,	****=<0.0001.	Where	a	protein	was	identified	in	only	a	single	mass	spectrometry	replicate,	precluding	statistical	analysis,	 this	 is	indicated	with	‘N.D.’,	otherwise	proteins	were	identified	in	at	least	2/3	replicates.	
	
Figure	 6.	 Cleavage	 of	 PABP	by	 the	 norovirus	 protease	NS6	 contributes	 to	
reduced	 cellular	 translation.	A)	 Illustration	of	 the	domain	structure	of	PABP.	B)	Western	blot	analysis	of	selected	eIF	proteins	 in	293T	cells	 transfected	with	the	MNV	protease	NS6.	C)	Western	blot	analysis	of	PABP	cleavage	over	a	MOI	10	infection	timecourse	in	BV-2	cells	D)	Analysis	of	global	translation	in	293T	cells	transfected	 with	 NS6	 assessed	 by	 35S-methionine	 pulse-labelling	 and	quantification	 on	 a	 phosphorimager.	 Error	 bars	 represent	 standard	 deviation	from	 3	 biological	 replicates.	 Statistical	 analysis	 was	 performed	 by	 one-way	ANOVA.	(*=<0.05,	**=<0.01,	***=<0.001,	****=<0.0001).			
Figure	7.	Modulation	of	PABP	cleavage	during	MNV	 infection	 is	 inhibitory	
for	viral	replication.	A)	Western	blot	analysis	of	BV-2	cells	infected	at	high	MOI	(10)	with	MNV	and	transfected	with	wild-type	or	non-cleavable	(Q440A)	PABP.	Viral	 titres	 obtained	 following	 low	MOI	 (0.01)	 infection	 of	 B)	 BV-2	 or	 C)	 RAW	264.7	cells	transfected	with	wild-type	or	a	non-cleavable	form	(Q440A)	of	PABP.	D)	Viral	titres	obtained	following	low	MOI	(0.01)	infection	of	cells	heterozygous	for	 a	 truncated	 form	of	 PABP.	 Error	 bars	 represent	 standard	 deviation	 from	3	biological	 replicates.	 Statistical	 analysis	 was	 performed	 by	 one-way	 ANOVA.	(*=<0.05,	**=<0.01,	***=<0.001,	****=<0.0001).		
	
Figure	8.	Induction	of	apoptosis	and	caspase	cleavage	of	eIF4F	components	
also	 contributes	 to	 altered	 translation	and	alters	 eIF4F	 composition.	A)	A	diagram	 illustrating	 the	 structure	 of	 eIF4GI	 and	 II	 as	 well	 as	 their	 caspase	cleavage	sites.	B)	Quantification	of	peptides	mapping	to	the	N-FAG,	M-FAG	or	C-FAG	domains	of	eIF4GI	binding	m7GTP-sepharose	beads	at	9h	post-infection.	C)	Western	 blotting	 against	 eIF4G	 and	 markers	 of	 apoptosis	 for	 an	 infection	timecourse	from	BV-2	or	D)	RAW	264.7	cells.	E)	Western	blotting	of	eIF4GI	or	II,	and	Viperin	 in	 the	presence	of	varying	amounts	of	 the	caspase	 inhibitor	z-vad-fmk.	 The	 specific	 viperin	 band	 is	 highlighted	 with	 ‘<’	 F)	 35S-Methionine	 pulse	labeling	 of	 BV-2	 cells	 Mock-	 or	 Infected	 with	 MNV	 at	 9h	 post-infection	 in	 the	presence	 or	 absence	 of	 the	 z-vad-fmk	 inhibitor.	 G).	 Quantification	 by	phosphorimaging	 of	 3	 biological	 repeats	 of	 experiment	 shown	 in	 F.	 H).	 Viral	titres	obtained	 following	 low	MOI	 (0.01)	 infection	of	BV-2	 cells	 treated	with	 z-vad-fmk	 (20μM),	 necrostatin-1	 (40μM)	 singly	 or	 in	 combination.	 N	 ≥	 3,	 Error	bars	 represent	 standard	 deviation.	 Statistical	 analysis	 was	 performed	 by	 one-way	ANOVA.	(*=<0.05,	**=<0.01,	***=<0.001,	****=<0.0001).		
	
Figure	9.	Model	for	modifications	to	eIF4F	during	norovirus	infection.	A)	In	healthy	 cells,	 the	 5’	 cap	 of	 mRNA	 is	 bound	 by	 eIF4E.	 This	 is	 bound	 by	 the	scaffolding	protein	eIF4G	which	allows	binding	to	other	initiation	factors	(eIF4A,	eIF3,	 PABP)	 as	well	 as	 recruitment	 to	 the	 ribosome	 via	 the	 eIF3	 complex.	 The	norovirus	protease	NS6	alone	can	inhibit	translation	through	cleavage	of	PABP,	though	larger	scale	alterations	to	the	initiation	factor	complex	are	not	observed.	In	infected	cells,	the	induction	of	apoptosis	can	result	in	further	modification	of	
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the	 eIF	 complex	 with	 caspase	 cleavage	 of	 C)	 eIF4GI	 separating	 the	 eIF4E	 and	PABP-binding	 regions	 and	 abolishing	 the	 circularization	 of	 translating	mRNAs.	D)	 Cleavage	 of	 eIF4GII	 by	 caspases	 is	 more	 extensive	 and	 in	 addition	 to	 the	effects	 observed	 with	 eIF4GI	 cleavage,	 separates	 the	 eIF4E	 and	 eIF3-binding	domains	of	eIF4GII,	preventing	recruitment	of	mRNA	to	the	ribosome.		
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